Moderna
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q4).
- Total institutional ownership (as a % of shares) was little changed.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 78.28% -0.09pp
- Institutions
- 1,222 -2
- As of
- 2026/Q4 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Stéphane Bancel | Chief Executive Officer | 5.49% |
| Noubar Afeyan | Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board | 0.55% |
| Stephen Hoge | President | 0.36% |
| Paul Sagan | Former Independent Non-Executive Director | 0.08% |
| Juan Andres | Chief Operating Officer | 0.03% |
| Shannon Klinger | Chief Legal Officer | 0.02% |
| James Mock | Chief Financial Officer | 0.01% |
| Francois Nader | Independent Non-Executive Director | 0.01% |
| Elizabeth Nabel | Independent Director | 0.00% |
| Sandra Horning | Independent Director | 0.00% |
| Shah Abbas Hussain | Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-04 | Juan Andres | Chief Operating Officer | Other Derivative Acquisition | +7,898 | $241.46 |
| 2026-11-04 | Juan Andres | Chief Operating Officer | Other Derivative Acquisition | +16,955 | -- |
| 2026-10-14 | Stephen Hoge | President | Derivative Exercise and Sale | -78,369 | $12.21–220.72 |
| 2026-10-14 | Stephen Hoge | President | Derivative Exercise and Retained | +74,536 | $12.21 |
| 2026-10-14 | Stephen Hoge | President | Intent to Sell (Form 144) | -39,145 | $220.72 |
| 2026-10-13 | Stephen Hoge | President | Intent to Sell (Form 144) | -39,224 | $213.48 |
| 2026-10-04 | Juan Andres | Chief Operating Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-10-04 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -704 | $190.01 |
| 2026-10-04 | James Mock | Chief Financial Officer | Derivative Exercise and Retained | +750 | -- |
| 2026-09-14 | Stephen Hoge | President | Derivative Exercise and Sale | -80,575 | $12.21–146.07 |
| 2026-09-14 | Stephen Hoge | President | Derivative Exercise and Retained | +72,330 | $12.21 |
| 2026-09-14 | Stephen Hoge | President | Intent to Sell (Form 144) | -40,281 | $146.07 |
| 2026-09-13 | Stephen Hoge | President | Intent to Sell (Form 144) | -40,294 | $144.13 |
| 2026-09-09 | James Mock | Chief Financial Officer | Automatic Disposition | -15,000 | $134.49 |
| 2026-09-09 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -19,836 | $30.96–134.49 |
| 2026-09-03 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Sale | -5,704 | $148.87 |
| 2026-09-03 | Shannon Klinger | Chief Legal Officer | Derivative Exercise and Retained | +6,093 | -- |
| 2026-09-03 | James Mock | Chief Financial Officer | Derivative Exercise and Sale | -5,704 | $148.87 |
| 2026-09-03 | James Mock | Chief Financial Officer | Derivative Exercise and Retained | +6,093 | -- |
| 2026-08-31 | Shannon Klinger | Chief Legal Officer | Sale to Issuer | -1,048 | $140.34 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Moderna discussion 0 comments